β-Tubulin genes and the basts for benzimidazole sensitivity of the opportunistic fungus Cryptococcus neoformans

References

1. Cooley R. N., Caten C. E. 1993; Molecular analysis of the Septoria nodorum β-tubulin gene and charact-erization of a benomyl-resistance mutation.. Mol Gen Genet 237:58–64.
   [Google Scholar]
2. Cruz M. C., Barlett M. S., Edlind T. D. 1994; In vitro susceptibility of the opportunistic fungus Cryptococcus neoformans to anthelmintic benzimidazoles.. Antimicrob Agents Chemother 38:378–380.
   [Google Scholar]
3. Davidse L. C., Flach W. 1977; Differential binding of methyl benzimidazole-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans.. J Cell Biol 72:164–193.
   [Google Scholar]
4. Davis L. C., Dibner M. D., Battey J. F. 1986; Basic Methods in Molecular Biology. New York:. Elsevier.
   [Google Scholar]
5. Edman J. C., Kwon-Chung K. J. 1990; Isolaticin of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation.. Mol Cell Biol 10:4538–4544
   [Google Scholar]
6. Fujimara M. K., Oeda M., Inoue H., Kato T. 1992; A single amino-acid substitution in the β-tubulin gene of Neurospora crassa confers both carbendazim resistance and. diethofencarb sensitivity.. Curr Genet 21:399–404
   [Google Scholar]
7. Goldman G. H., Temmerman W., Jacobs D., Contreras R., Van Montagu M., Herrrera-Estrella A. 1993; A iiucleotide substitution in one of the β-tubulin genes of Trichoderma viride confers resistance to the antimitotic drug methyl benzimidazole- 2-yl-carbamate.. Mol Gen Genet 240:73–80
   [Google Scholar]
8. Hay J. R. 1991; Clinical manifestations and rnanagement of cryptococcoses in the compromised patient. In Fungal Infection in the Compromised Patient. Edited by D. W. Warnock & M. D. Richardson. New York:. John Wiley.
   [Google Scholar]
9. Jung M. K., Oakley B. R. 1990; Identification of an amino acid substitution in the benA β-tubulin gene of Aspergillus nidulans that confers thiabendazole resistance and bmomyl supersensitivity.. Cell Motil Cytoskel 17:87–94
   [Google Scholar]
10. Jung M. K., Wilder I. B., Oakley B. R. 1992; Amino acid alterations in the benA (β-tubulin) gene of Aspergillus nidulans that confer benomyl resistance.. Cell Motil Cytoskel 22:170–174
    [Google Scholar]
11. Katiyar S. K., Wilder I. B., Edlind T. D. 1994; β-Tubulin genes of Trichomonasv vaginalis.. Mol Biochem Parasitol 64:33–42
    [Google Scholar]
12. Katiyar S. K., Gordon I. B., Edlind V. R., McLaughlin G. L., Edlind T. D. 1994; Antiprotozoal activities of benzimidazoles and correlations with β-tubulin sequence.. Antimicrob Agents Chemother 38:2086–2090
    [Google Scholar]
13. Kozak M. 1986; Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.. Cell 44:283–292
    [Google Scholar]
14. Lacey E. 1988; The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of resistance to benzimidazoles.. Int J Parasitol 18:885–936
    [Google Scholar]
15. Lewis S. A., Gilmartin M. E., Hall J. L., Cowan N. J. 1985; Three expressed sequences within the human β-tubulin multigene family each define a distinctive isotype.. J Mol Biol 182:11–20
    [Google Scholar]
16. Li J., Katiyar S. K., Edlind T. D. 1996; Site-directed mutagenesis of Saccharomyces cerevisiae β-tubulin: interaction between residue 167 and benzimidazole compounds.. FEBS Lett 385:7–10
    [Google Scholar]
17. May S. G., Tsang M. L. S., Smith H., Fidel S., Morris N. R. 1987; Aspergiffus nidulans β-tubulin genes are unusually divergent.. Gene 55:231–243
    [Google Scholar]
18. Moore T. D. E., Edman J. C. 1993; The α-mating type locus of Cryptococcus neoformans contains a peptide pheromone gene.. Mol Cell Biol 13:1962–1970
    [Google Scholar]
19. Ohrbach M. J., Porro E. B., Yanofsky C. 1986; Cloning and characterization of the gene for β-tubulin from a benomyl resistant mutant of Neurospora crassa and its use as a dominant selectable marker.. Mol Cell Biol 6:2452–2461
    [Google Scholar]
20. Panther L. A., Sande M. A. 1990; Cryptococcal meningitis in the acquired immunodeficiency syndrome.. Semin Respir Infect 5:138–145
    [Google Scholar]
21. Powderly W. G. 1992; Therapy for cryptococcal meningitis in patients with AIDS.. Clin Infect Dis 14:S54–S59
    [Google Scholar]
22. Russo P., Juuti J. T., Raudaskoski M. 1992; Cloning, sequence and expression of a β-tubulin-encoding gene in the homobasidiomycete Schizophyllum commune.. Gene 119:175–182
    [Google Scholar]
23. Sirawaraporn W., Cao M., Santini D. V., Edman J. C. 1993; Cloning, expression, and characterization of Cryptococcus neoformans dihydrofolate reductase.. J Biol Chem 268:8888–8892
    [Google Scholar]
24. Sugar A. M., Stern J. J., Dupont B. 1990; Overview: treatment of cryptococcal meningitis.. Rev Infect Dis 12:S338–S348
    [Google Scholar]
25. Thomas J. H., Neff N. F., Botstein D. 1985; Isolation and characterization of mutations in the β-tubulin gene of Saccharomyces cerevisiae.. Genetics 112:715–734
    [Google Scholar]
26. Tolkacheva T., McNamara P., Piekarz E., Courchesne W. 1994; Cloning of a Cryptococcus neoformans gene, GPAl, encoding a G-protein α-subunit homolog.. Infect Immun 62:2849–2856
    [Google Scholar]
27. Williamson P. R. 1994; Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase.. J Bacteriol 176:656–664
    [Google Scholar]